Clinical Trial Update: KONVERT-AF - Relevance of Point in Time for Conversion of Acute Atrial Fibrillation [NA]

View source ↗

Summary

The KONVERT-AF trial evaluating the relevance of timing for conversion of acute atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Atrial Fibrillation Network | Conditions: Atrial Fibrillation | NA | Status: WITHDRAWN